Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Beyond state-of-the-art battery recycling by increasing the selectivity and specificity of efficient pre-processing technologies (BeyondBattRec)

Framework: Horizon Europe — Global Challenges and European Industrial Competitiveness
Programme: Climate, Energy and Mobility
Theme: Energy
Destination: Cross-sectoral solutions for the climate transition
Action type: Research and Innovation actions
Partnership: Batteries (co-programmed)
Countries involved: Denmark,United Kingdom,Germany,Norway,Spain,Austria,France
Call: Advanced sustainable and safe pre-processing technologies for End-of-Life (EoL) battery recycling (Batt4EU Partnership) (HORIZON-CL5-2024-D2-01, 2024)
Start date: 2024-12-01
End date: 2028-11-30
Duration (months): 48.0
Total project cost (EUR): 7453524.75
EU funding (EUR): 7453524.75
Participants: 12
Project status: SIGNED

Europe aims to reach climate neutrality and a circular economy by 2050. Current practices to recycle batteries are not designed for the full valorisation of the battery materials and, therefore, are not coherent with the European ambitions. To design the vertical battery recycling process compatible with the requirements of circular economy, BeyondBattRec aims at integrating emerging technological and digital tools to enhance the battery recycling rate. The project introduces innovative principles and practices at the component level and rationally integrates the developed components to recover valuable materials with a constant focus on carbon footprint according to the request in Annex II of the new EU Directive (EU) 2019/1020. To achieve its objective, BeyondBattRec puts together a multidisciplinary 13-partner consortium from 7 European member states, consisting of industries, academia, and research & technology organizations. The project targets battery recyclers, manufacturers and technology providers as the end users due to their importance in realizing the objectives of Batt4EU in transforming European battery industry to make it circular and achieve overall climate neutrality at EU level by 2050, while enhancing their global competitiveness. Thanks to innovative steps beyond state of art, BeyondBattRec will allow to comply also with other 2 Annexes of the above Directive (Annex X for management of materials subject to risk of supply for Europe and Annex XII related to minimum recovery rate for said risky and strategic metals and requesting the following recovery rate at the horizon of 2031: (a) 95 % for cobalt; (b) 95 % for Cooper; (c) 80 % for lithium;(d) 95 % for nickel. BeyondBattRec builds on the success of former initiatives and projects which have delivered technological, methodological, patents and largely Europe Dissemination under join venture and licenses. Thanks to those community assets, BeyondBattRec will convincingly and coherently leverage and advance to achieve its objectives.

Keywords: battery recycling,dismantling,deactivation,sorting,materials recovery,non metal materials recovery
Design of Flow-Photoelectrolyzer (PhotoElectroFlow)

Framework: Horizon Europe — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Proof of concept grants
Action type: ERC actions
Countries involved: Germany
Call: ERC PROOF OF CONCEPT GRANTS (ERC-2025-POC, 2025)
Start date: 2026-01-01
End date: 2027-06-30
Duration (months): 18.0
Total project cost (EUR): 150000.0
EU funding (EUR): 150000.0
Participants: 1
Project status: SIGNED

The EU strongly strives for a sustainability transformation, and the EU Commission's Green Deal accelerates climate neutrality by 2050, with a modern and competitive economy. Climate neutrality of the chemical industries calls for innovative resource- and energy-economical technologies to harvest renewable forms of energy and prevent chemical waste. Breakthrough studies demonstrated the unique potential of harnessing both solar and electrical energy for sustainable syntheses. Thereby, chemical waste formation can be minimized, while enabling innovative scenarios that neither electrochemistry nor photochemistry can achieve. Specifically, the merger of photoelectrochemically-enabled molecular assembly with the cathodic hydrogen formation constitutes ideal resource-economic synthesis. Unfortunately, photoelectrocatalysis continues to be limited to reactions on small mmol lab-scale, preventing the translation of recent exciting trends to the next level of industrial process scale. The absence of a commercially available reactor represents a major limitation to unleash the full potential of photoelectrochemical chemistry for practitioners. The transfer to continuous flow bears great opportunities for photoelectrochemistry in chemical, agrochemical and pharmaceutical industries. The overarching objective of PhotoElectroFlow is to devise a first continuous flow electrolyzer for scalable photoelectrochemical transformations in a safe and robust manner on gram to kilogram scale. Thus, we will provide a most-user-friendly technology, closely collaborating with partners in industry, to harvest the unique synergy of light and electricity. Evaluation of the PhotoElectroFlow electrolyzer will be benchmarked in molecular transformations of practical importance to chemists in academia as well as in pharmaceutical, agrochemical and chemical industries. The devise will be patented and represents the foundation for a start-up initiative towards circular carbon-neutral industries.
SaorTrack: Wireless Position Tracking in the OR (Saor Track)

Framework: Horizon Europe — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Proof of concept grants
Action type: ERC actions
Countries involved: Ireland
Call: ERC PROOF OF CONCEPT GRANTS (ERC-2024-POC, 2024)
Start date: 2024-12-01
End date: 2026-05-31
Duration (months): 18.0
Total project cost (EUR): 150000.0
EU funding (EUR): 150000.0
Participants: 1
Project status: SIGNED

Magnetic tracking technology is the gold-standard for in vivo navigation where line-of-sight is not available. Magnetic tracking reduces dependence on radiation imaging and provides highly accurate tracking of instruments, tools and cameras inside the patient. However, existing commercial and research solutions are wired. High-accuracy wireless tracking can transform existing clinical applications of magnetic tracking such as electrophysiology (EP) mapping of the beating heart by dramatically reducing wire clutter in the OR, and simplifying the clinical workflow. More importantly, wireless tracking can open up new clinical applications where high-accuracy position navigation are not feasible to date, such as in capsule endoscopy. Existing capsules provide video feed to the clinical team without localisation to the patient’s anatomy. Our wireless position navigation design can seamlessly integrate with existing technology solutions to provide highly accurate localisation of abnormalities within the colon, resulting in more precise and faster diagnosis. This project builds on ground-breaking innovations from the ERC Deep Field project to demonstrate proof-of-concept pre-clinical validation for our wireless magnetic navigation design in high-value existing applications in cardiology such as EP mapping, as well as demonstrating feasibility of high-accuracy position navigation in capsule endoscopy for the first time.
CircHtt in brain development and Huntington`s Disease: elucidating in vivo brain functions of a novel circular RNA molecule stemming from the Htt locus (BrainCircHD)

Framework: Horizon Europe — Excellent Science
Programme: Marie Skłodowska-Curie Actions (MSCA)
Theme: Marie Skłodowska-Curie
Destination: Postdoctoral Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Life Sciences
Countries involved: Italy
Call: MSCA Postdoctoral Fellowships 2021 (HORIZON-MSCA-2021-PF-01, 2021)
Start date: 2023-09-01
End date: 2026-07-31
Duration (months): 35.0
Total project cost (EUR): 188590.08
EU funding (EUR): 188590.08
Participants: 1
Project status: SIGNED

I am a neuroscientist specialized on brain development and genetic brain disorders. During my PhD with Dr. Gaia Novarino (IST Austria) I developed a strong expertise in using in vivo mouse models and a large number of different techniques to investigate the underlying cause of intellectual disability and autism. My work helped to better understand the pathophysiologic mechanisms driving these complex neurodevelopmental conditions, as well as the process of brain development more in general. Now, I aim to expand my research profile to neurodegeneration and the non-coding genome, specifically circular RNAs (circRNA). As a postdoctoral researcher in the lab of Dr. Biagioli at Dep. CIBIO (UniTN) I seek to combine my strong background in functional in vivo studies with her outstanding expertise in Huntington`s Disease (HD) research and epigenetics to elucidate a novel regulatory pathway in HD. In this proposal, I designed a dedicated research and training plan that will significantly expand my scientific portfolio and uncover the in vivo functional role(s) of circHTT, a newly discovered circRNA molecule -discovered and initially characterized by Dr. Biagioli’s lab - stemming from the HD locus. We will study its mouse orthologue, circHtt, focusing on expression dynamics and pattern during development and aging and visualize its cellular and subcellular localization in the brain. We will analyse its relevance for HD pathology by using HD mouse models and uncover its molecular brain function(s) by exploiting the innovative and highly specific CRISPR-Cas13 knock-down machinery in vivo. The results of this project will highlight a novel regulatory network in HD pathophysiology in which circHTT may act as modifier of/or novel biomarker for HD progression, or represent a novel molecular drug target. This award is vital for me to return from maternity leave and join the Biagioli group. It will significantly contribute to my career perspectives inside and outside of academia.

Keywords: huntington s disease non coding rnas circrnas brain function brain development
SINGULARITY: The first quantum software toolbox for finance (SINGULARITY)

Framework: Horizon Europe — Innovative Europe
Programme: The European Innovation Council (EIC)
Theme: EIC Accelerator
Destination: Open to supporting projects in all areas of science, technology,...
Action type: EIC actions
Countries involved: Spain
Call: EIC Accelerator Open 2021 (HORIZON-EIC-2021-ACCELERATOROPEN-01, 2021)
Start date: 2022-09-01
End date: 2024-12-31
Duration (months): 28.0
Total project cost (EUR): 3571428.75
EU funding (EUR): 2500000.0
Participants: 2
Project status: CLOSED

Quantum computers are reaching a scale where they can start delivering value. The quantum software market is estimated to grow at a CAGR of 42% over the next five years to reach €1.42 billion by 2027. McKinsey highlighted finance as the earliest high-impact application of quantum computing. We have been pioneers in this space. We authored one of the seminal papers in the field. Then we developed a quantum software toolkit for finance, and results from beta testing with leading financial institutions brought us to the limelight. Now, thought leaders like McKinsey, The Economist, BCG, and Forbes point at Multiverse as a leading firm in quantum finance. Quantum computing is a strategic technology for Europe. Anglo-Saxon firms dominate both quantum and finance. Yet, Multiverse is leading this race. However, we must act decisively to keep this position. With the EIC support, we will keep the lead and materialise the promise of quantum for financial applications.

Keywords: quantum computing,finance,quantum for finance
Sustainable COVID-19 Vaccination for Long-term Vaccine Immunity and Effectiveness (SOLVE)

Framework: Horizon Europe — Global Challenges and European Industrial Competitiveness
Programme: Health
Theme: Health
Destination: Tackling diseases and reducing disease burden
Action type: Research and Innovation actions
Countries involved: France,Spain,Belgium,Italy,Switzerland
Call: Pandemic preparedness and response: Understanding vaccine induced-immunity (HORIZON-HLTH-2023-DISEASE-03, 2023)
Start date: 2024-01-01
End date: 2028-12-31
Duration (months): 60.0
Total project cost (EUR): 8972900.0
EU funding (EUR): 8972900.0
Participants: 11
Project status: SIGNED

Despite the rapid development of various SARS-CoV-2 vaccines, the control of the pandemic is hampered by the constant emergence of SARS-CoV-2 variants escaping vaccine-induced immunity and the waning of immunity. SOLVE will tackle these challenges by deciphering the mechanisms of induction of long-lasting immunity and evaluating new vaccine platforms. To achieve this goal, an integrated plan has been developed including six pillars: 1) Vaccine discovery and design; 2) Head-to-head evaluation of the immune response and long-lasting immunity induced by four vaccine platforms in the preclinical setting; 3) Validation of the pre-clinical results in an experimental medicine trial (EMT); 4) Immune mechanisms of long-lasting immunity; 5) Data Science; 6) Determinants of population adherence to vaccination. New immunogens including key mutations from most recent variants in RBD and Nucleocapsid sequences highly conserved across Sarbecoviruses, will be delivered through: antigen-targeting to dendritic cells (DC), i.e., CD40 DC-targeting, nanoparticles, a MVA vector and 2nd generations of mRNAs. SOLVE will evaluate in depth the immunogenicity of these vaccines in the preclinical setting, and in an EMT testing two vaccines, i.e., CD40 DC-targeting and MVA with available GMP clinical lots. SOLVE will benefit from the most advanced technologies to identify the mechanisms of long-lasting immunity. Integrative analyses of high throughput data, including from large cohorts, will provide insights for identification of factors (demographics, vaccines, immunity) which impact quality and longevity of immunity. SOLVE will investigate stakeholders’s perspective on the acceptability of large vaccination campaigns to improve implementation of next generation of vaccines in a preparedness track. The consortium gathers 8 renowned public/private institutions supported by a governance facilitating fast sharing of information to keep up with a tight schedule imposed by the pandemic.

Keywords: covid 19,vaccine platforms dc targeting,mrna,mva,nanoparticles,long lasting immunity,data science,adherence to vaccination
Solutions for CRitical Raw materials - a European Expert Network 3 (SCRREEN3)

Framework: Horizon Europe — Global Challenges and European Industrial Competitiveness
Programme: Digital, Industry and Space
Theme: Industry
Destination: Increased Autonomy in Key Strategic Value Chains for Resilient Industry
Action type: Coordination and support actions
Countries involved: France,Germany,Belgium,Greece,Spain,Netherlands,Finland,Switzerland,Austria,Slovakia,Italy,Slovenia
Call: Expert network on Critical raw materials (CSA) (HORIZON-CL4-2023-RESILIENCE-01, 2023)
Start date: 2024-01-01
End date: 2027-12-31
Duration (months): 48.0
Total project cost (EUR): 3356847.33
EU funding (EUR): 2998759.25
Participants: 24
Project status: SIGNED

Based on the experience and background of SCRREEN1 and SCRREEN2, the prolongation of the project SCRREEN3 will continue to develop and animate an Expert Network which will contribute to expert advice in support of decision-making at the EU level covering all the raw materials and their value chains screened in the CRMs assessment.

Keywords: raw materials,circular economy
Federated decentralized trusted dAta Marketplace for Embedded finance (FAME)

Framework: Horizon Europe — Global Challenges and European Industrial Competitiveness
Programme: Digital, Industry and Space
Theme: Digital
Destination: World-leading Data and Computing Technologies
Action type: Innovation actions
Partnership: AI-DATA-ROBOTICS (co-programmed)
Countries involved: Italy,Belgium,Spain,Israel,Greece,Cyprus,Romania,Portugal,Türkiye,Ireland,Norway,Slovenia,Slovakia,Germany,Netherlands
Call: Technologies and solutions for data trading, monetizing, exchange and interoperability (AI, Data and Robotics Partnership) (IA) (HORIZON-CL4-2022-DATA-01, 2022)
Start date: 2023-01-01
End date: 2025-12-31
Duration (months): 36.0
Total project cost (EUR): 16621393.75
EU funding (EUR): 12889656.25
Participants: 37
Project status: SIGNED

FAME is a joint effort of world-class experts in data management, data technologies, the data economy, and digital finance to develop, deploy and launch to the global market a unique, trustworthy, energy-efficient, and secure federated data marketplace for Embedded Finance (EmFi). The FAME marketplace will alleviate the proclaimed limitations of centralized cloud marketplaces towards demonstrating the full potential of the data economy. In this direction, the project will enhance a state of the art data marketplace infrastructure (i.e., H2020 i3-Market marketplace) with novel functionalities in three complementary directions namely: • Secure, interoperable, and regulatory compliant data exchange across multiple federated cloud-based data providers in-line with emerging European initiatives like GAIA-X. • Decentralized, programmable, data assets trading and pricing leveraging blockchain tokenization techniques (including support for accruing data assets value in NFTs). • Integration of trusted and Energy Efficient (EE) analytics based on novel technologies such as Quantitative Explainable AI, Situation Aware Explainability (SAX), incremental EE analytics, and edge analytics. FAME will become operational in a federated cloud environment with multiple providers of EmFi data assets, including datasets, AI/ML models, and more. It will become interconnected with more than 12 data marketplaces that are operated by the project partners, as well as with other data infrastructures that will support the implementation of 7 pilots. Through this process, the catalog of the FAME marketplace will be populated with a critical mass of 1000+ data assets. Furthermore, FAME will establish a Learning Center (LC) for tech and non-tech users, as this is a key prerequisite for unlocking the potential of the data economy. FAME will build a vibrant community of EmFi stakeholders around the FAME platform, which will serve as a catalyst for the sustainability of the project’s results.

Keywords: federated marketplaces,decentralized data management,data pricing,data trading,explainable artificial intelligence,energy efficient analytics,embedded finance,fintech
Gendered Innovation Living Labs (GILL)

Framework: Horizon Europe — Widening Participation and Strengthening the European Research Area
Programme: Reforming and enhancing the European R&I System
Theme: Reforming and enhancing the European R&I System
Destination: Reforming and enhancing the European R&I System
Action type: Research and Innovation actions
Countries involved: Belgium,Italy,Spain,Greece,Romania,Denmark,United Kingdom,France,Germany,Czechia
Call: Living Lab for gender-responsive innovation (HORIZON-WIDERA-2022-ERA-01, 2022)
Start date: 2023-01-01
End date: 2025-12-31
Duration (months): 36.0
Total project cost (EUR): 2589225.0
EU funding (EUR): 2589225.0
Participants: 17
Project status: SIGNED

GILL, coordinated by ENoLL, the largest network of Living Labs (LL), will develop a pan-European collaboration and learning hub based on the LL principles to become the open innovation framework for all European actors for open gendered innovation. The GILL “LL” will co-create sustainable mechanisms to increase gender responsive smart innovation and entrepreneurship (GRISE) by fixing practices and culture across the European ecosystems. GILL will focus on 4 macro-objectives: a) to enable the organisational and cultural changes, b) to enhance professional development, c) to increase the integration of gender and diversity into product design, technologies and innovation, and d) to allow gendered educational practices. In parallel, GILL actions will act along a matrix of horizontal spheres of innovation (individual & team, tools & methods, innovation & products, societal processes) and three vertical priorities (Health and resilience, Green & Digital transition). GILL will be implemented through an iterative co-creation approach structured on a four-phases cycle - understand, co-design, implement, evaluate - repeated twice to incorporate the feedbacks and evaluation results in fine-tuned and validated results. 15 Action-Oriented Experimentations in 8 European countries will develop new approaches to GRSIE, test, evaluate the changes, and thereby validate GILL’s outputs in real-life open ecosystems. Through this cycle, GILL will deliver a systemic review of barriers to GRSIE leading to the co-design of proven methodologies, services, and tools for GRSIE to be made available on a sustainable and easy to use platform. In line with the LL methodology, co-creation and open innovation will be fostered among the main actors of the Quadruple Helix model - citizens, government, industry, and academia - who will be engaged all along the project through different participatory activities.

Keywords: living labs,open innovation ecosystem,co creation,quadruple helix,gender responsive smart innovation and entrepreneurship,open gendered innovation,intersectionality,fix culture and practices
MEDical Research Valorisation through Intelligent Engagement of Citizens for Well-being (MEDViEW)

Framework: Horizon Europe — Widening Participation and Strengthening the European Research Area
Programme: Reforming and enhancing the European R&I System
Theme: Reforming and enhancing the European R&I System
Destination: Reforming and enhancing the European R&I System
Action type: Coordination and support actions
Countries involved: Lithuania,Greece,Luxembourg,Slovenia,Netherlands
Call: Experimentation and exchange of good practices for value creation (HORIZON-WIDERA-2024-ERA-02, 2024)
Start date: 2025-05-01
End date: 2027-04-30
Duration (months): 24.0
Total project cost (EUR): 999062.5
EU funding (EUR): 999062.5
Participants: 6
Project status: SIGNED

MEDVIEW builds on the growing recognition that achieving good health in a community requires much more than medical and technical solutions available only in selected places and circumstances. Citizens’ health priorities stem from their everyday experiences and needs and differ from professionals’ priorities. There is a growing demand for a more "human-centric" approach to tackle the complexity of achieving overall human well-being. It is widely accepted that involving citizens in the design of products, services, and policies that impact their health, lives, and communities is thought to improve their overall quality and effectiveness. Citizens’ voices can act as a mechanism for change ensuring that the created solutions are more integrated around communities’ needs instead of centered on organisations’ traditional remits. MEDVIEW aims to create an enabling environment for innovation, collaboration, and effective co-creation between industry partners, citizens (patients, community members), health practitioners, doctors, researchers, academia, and policymakers to address the complex issue of human health & well-being. To succeed so, we have carefully selected partners from three WIDENING countries [LT, GR, SLO] and two of non WIDENING countries [LUX, BE] addressing the following selection criteria: - Wide geographical reach, representing a rich tapestry of cultures, languages, and healthcare/wellbeing systems - Specialized expertise and a solid track record of all partners in coordination and support activities both at the national as well as in an international level - Representation of all target groups as defined by the Call The project will ultimately deliver the MEDVIEW Knowledge Valorisation Implementation Guide, a complete practical guide, and the relevant tools comprised of methods, practices, and procedures for the deployment of an open innovation space for effective knowledge valorisation in the field of well-being.